Compile Data Set for Download or QSAR
Report error Found 166 Enz. Inhib. hit(s) with all data for entry = 10361
TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530473(WO2022076764, Example 2)
Affinity DataEC50:  3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530552(WO2022076764, Example 81)
Affinity DataEC50:  4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530472(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-phenyl-1H-im...)
Affinity DataEC50:  4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530554(N-[l-(2,6-Ddifluoro-4-methoxyphenyl)-4-(3-methanes...)
Affinity DataEC50:  5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530491(WO2022076764, Example 20)
Affinity DataEC50:  5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530488(WO2022076764, Example 17)
Affinity DataEC50:  5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530496(WO2022076764, Example 25)
Affinity DataEC50:  6nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530545(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-hydroxycy...)
Affinity DataEC50:  7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530481(WO2022076764, Example 10)
Affinity DataEC50:  7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530474(WO2022076764, Example 3)
Affinity DataEC50:  8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530479(WO2022076764, Example 8)
Affinity DataEC50:  8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530501(WO2022076764, Example 30)
Affinity DataEC50:  9nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530495(WO2022076764, Example 24)
Affinity DataEC50:  9nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530553(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(3-((2,2,2-t...)
Affinity DataEC50:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530514(WO2022076764, Example 43)
Affinity DataEC50:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530547(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-(4-hydroxycy...)
Affinity DataEC50:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530548(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((6-fluoro-1...)
Affinity DataEC50:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530534(N-[l-(2,6-Difluoro-4-methoxyphenyl)-4-(piperidin-4...)
Affinity DataEC50:  10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530475(WO2022076764, Example 4)
Affinity DataEC50:  11nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530511(WO2022076764, Example 40)
Affinity DataEC50:  11nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530535(4-(Difluoromethoxy)-N-[1-(4-methoxyphenyl)-4-(pipe...)
Affinity DataEC50:  11nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530516(WO2022076764, Example 45)
Affinity DataEC50:  14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530483(WO2022076764, Example 12)
Affinity DataEC50:  15nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530500(WO2022076764, Example 29)
Affinity DataEC50:  15nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530509(WO2022076764, Example 38)
Affinity DataEC50:  15nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530505(WO2022076764, Example 34)
Affinity DataEC50:  16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530508(WO2022076764, Example 37)
Affinity DataEC50:  16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530503(WO2022076764, Example 32)
Affinity DataEC50:  18nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetN-formyl peptide receptor 2(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530491(WO2022076764, Example 20)
Affinity DataEC50:  19nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530510(WO2022076764, Example 39)
Affinity DataEC50:  21nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530543(WO2022076764, Example 72)
Affinity DataEC50:  22nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530546(N-( 1-(2,6-Difluoro-4-methoxyphenyl)-4-(2-azaspiro...)
Affinity DataEC50:  23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530486(WO2022076764, Example 15)
Affinity DataEC50:  23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530544(N-(l-(2,6-Difluoro-4-methoxyphenyl)-4-((5-methyl-l...)
Affinity DataEC50:  23nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530482(WO2022076764, Example 11)
Affinity DataEC50:  24nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530512(WO2022076764, Example 41)
Affinity DataEC50:  26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530517(WO2022076764, Example 46)
Affinity DataEC50:  27nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530487(WO2022076764, Example 16)
Affinity DataEC50:  27nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530537(4-[l-(2,6-Difluoro-4-methoxyphenyl)-2-[4-(difluoro...)
Affinity DataEC50:  28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530490(WO2022076764, Example 19)
Affinity DataEC50:  28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530494(WO2022076764, Example 23)
Affinity DataEC50:  28nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530492(WO2022076764, Example 21)
Affinity DataEC50:  29nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530507(WO2022076764, Example 36)
Affinity DataEC50:  31nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530541(N-(1-(2,6-Difluoro-4-methoxyphenyl)-4-isopropyl-1H...)
Affinity DataEC50:  31nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetN-formyl peptide receptor 2(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530500(WO2022076764, Example 29)
Affinity DataEC50:  32nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530533(WO2022076764, Example 62)
Affinity DataEC50:  32nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530478(WO2022076764, Example 7)
Affinity DataEC50:  33nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530518(WO2022076764, Example 47)
Affinity DataEC50:  35nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetN-formyl peptide receptor 2(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530473(WO2022076764, Example 2)
Affinity DataEC50:  38nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

TargetfMet-Leu-Phe receptor(Human)
Bristol-Myers Squibb

WIPO
LigandPNGBDBM530485(WO2022076764, Example 14)
Affinity DataEC50:  39nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
WIPO WO2022076764

Displayed 1 to 50 (of 166 total ) | Next | Last >>
Jump to: